Original language | English (US) |
---|---|
Pages (from-to) | 1852-1856 |
Number of pages | 5 |
Journal | Liver Transplantation |
Volume | 27 |
Issue number | 12 |
DOIs | |
State | Published - Dec 2021 |
ASJC Scopus subject areas
- Surgery
- Hepatology
- Transplantation
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: Liver Transplantation, Vol. 27, No. 12, 12.2021, p. 1852-1856.
Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - Antibody Response to Severe Acute Respiratory Syndrome-Coronavirus-2 Messenger RNA Vaccines in Liver Transplant Recipients
AU - Strauss, Alexandra T.
AU - Hallett, Andrew M.
AU - Boyarsky, Brian J.
AU - Ou, Michael T.
AU - Werbel, William A.
AU - Avery, Robin K.
AU - Tobian, Aaron A.R.
AU - Massie, Allan B.
AU - Hamilton, James P.A.
AU - Garonzik-Wang, Jacqueline M.
AU - Segev, Dorry L.
N1 - Funding Information: This research was made possible with the generous support of the Ben-Dov family. This work was supported by Grants T32DK007732 (Andrew M. Hallett), F32DK124941 (Brian J. Boyarsky), K01DK101677 (Allan B. Massie), and K23DK115908 (Jacqueline M. Garonzik-Wang) from the National Institute of Diabetes and Digestive and Kidney Diseases; Grant K24AI144954 (Dorry L. Segev) from the National Institute of Allergy and Infectious Diseases; and a grant from the Transplantation and Immunology Research Network of the American Society of Transplantation (William A. Werbel). The analyses described here are the responsibility of the authors alone and do not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the US government. Funding Information: Dorry L. Segev has the following financial disclosures: consulting and/or speaking honoraria from Sanofi, Novartis, CSL Behring, Jazz Pharmaceuticals, Veloxis, Mallinckrodt, and Thermo Fisher Scientific. Robin K. Avery has the following financial disclosures: study/grant support from Aicuris, Astellas, Chimerix, Merck, Oxford Immunotec, Qiagen, and Takeda/Shire. The other authors of this manuscript have no financial disclosures to make. Funding Information: This research was made possible with the generous support of the Ben‐Dov family. This work was supported by Grants T32DK007732 (Andrew M. Hallett), F32DK124941 (Brian J. Boyarsky), K01DK101677 (Allan B. Massie), and K23DK115908 (Jacqueline M. Garonzik‐Wang) from the National Institute of Diabetes and Digestive and Kidney Diseases; Grant K24AI144954 (Dorry L. Segev) from the National Institute of Allergy and Infectious Diseases; and a grant from the Transplantation and Immunology Research Network of the American Society of Transplantation (William A. Werbel). The analyses described here are the responsibility of the authors alone and do not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the US government.
PY - 2021/12
Y1 - 2021/12
UR - http://www.scopus.com/inward/record.url?scp=85114951838&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85114951838&partnerID=8YFLogxK
U2 - 10.1002/lt.26273
DO - 10.1002/lt.26273
M3 - Article
C2 - 34407309
AN - SCOPUS:85114951838
SN - 1527-6465
VL - 27
SP - 1852
EP - 1856
JO - Liver Transplantation
JF - Liver Transplantation
IS - 12
ER -